|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.035 USD | +2.78% |
|
+7.41% | -13.62% |
| 05-09 | Transcript : Xeris Biopharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
| 05-09 | Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q1 Revenue $40.6M, vs. Street Est of $41.8M | MT |
Xeris Biopharma Holdings, Inc. provided revenue guidance for the full year 2024. For the year, the company expects tightening 2024 total revenue guidance to $175 million to $200 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.62% | 294M | |
| +34.02% | 693B | |
| +29.39% | 584B | |
| -2.99% | 372B | |
| +20.59% | 332B | |
| +6.59% | 294B | |
| +14.11% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.78% | 168B |
XERIS BIOPHARMA HOLDINGS, INC. 
